Novo Nordisk Pharmaceuticals, Inc. v. Bio-Technology General Corp.
Court of Appeals for the Federal Circuit
1Opinion of the Court
SCHALL, Circuit Judge.
Novo Nordisk Pharmaceuticals, Inc. and Novo Nordisk A/S (collectively, “Novo”) appeal from the final judgment of the United States District Court for the District of Delaware in their suit for patent infringement against Bio-Technology General Corp. and Teva Pharmaceuticals USA, Inc. The district court held the two claims of Novo Nordisk A/S’s U.S. Patent No. 5,633,352 (“the ’352 patent”) invalid by reason of anticipation under 35 U.S.C. § 102(a). The court also held the patent unenforceable due to inequitable conduct. Novo Nordisk Pharms., Inc. v. Bio-Technology Gen.…
2Cases cited25 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Kingsdown Medical Consultants, Ltd. And E.R. Squibb & Sons, Inc. v. Hollister IncorporatedCourt of Appeals for the Federal Circuit · 1988
- Molins Plc, and John Coventry Smith, Jr. v. Textron, Inc., Kearney & Trecker Corporation, and Avco CorporationCourt of Appeals for the Federal Circuit · 1995
- Allen Engineering Corporation v. Bartell Industries, Inc. And Darragh CompanyCourt of Appeals for the Federal Circuit · 2002
- Amgen Inc., Plaintiff-Cross v. Hoechst Marion Roussel, Inc. (Now Known as Aventis Pharmaceuticals, Inc.) and Transkaryotic Therapies, Inc.Court of Appeals for the Federal Circuit · 2003
20 more not listed; retrieve them via the Exa API.
3Cited by41 opinions
- Digital Control v. The Charles MacHine Works (Also Known as Ditchwitch)Court of Appeals for the Federal Circuit · 2006
- In Re GleaveCourt of Appeals for the Federal Circuit · 2009
- Kennametal, Inc. v. Ingersoll Cutting Tool CompanyCourt of Appeals for the Federal Circuit · 2015
- Yoon Ja Kim v. Conagra Foods, Inc.Court of Appeals for the Federal Circuit · 2006
- SRI International, Inc. v. Internet Security Systems, Inc.Court of Appeals for the Federal Circuit · 2008
36 more not listed; retrieve them via the Exa API.